medline.ch Onkologie Urologische Tumoren

	Case Report: Prostate adenocarcinoma with peritoneal carcinomatosis and elevated CEA mimicking colorectal cancer: a diagnostic dilemma. Front Oncol Majeed H, Shelman N, Patel JA, Veedu JS, Selene II, Whitesell A, Myint ZW. PMID: 41994658 [PubMed - in process]
	Redefining standards: a comprehensive systematic review of practice changing advances in GU oncology from ASCO and ESMO 2025. Front Endocrinol (Lausanne) Ismaili N. PMID: 41993992 [PubMed - indexed for MEDLINE]
	Phase I dose-escalation study of [Â¹â·â·Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer. Theranostics Wang J, Wang R, Xiang J, Yang H, Zhao T, Guo F, Liang Y, Zhu Z, Zhang J. PMID: 41993609 [PubMed - indexed for MEDLINE]
	Apalutamide-induced severe cutaneous adverse reactions in prostate cancer: a comprehensive review of reported cases and clinical strategies. Front Pharmacol Wang T, Liu S, Yuan R. PMID: 41993591 [PubMed]
	Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAKâ€‘STAT pathway. Oncol Rep Yun Y, Ji X, Hu S, Wu T, Liu Y, Li Z, Sun Z, Zhou P, Yang L, Yu W. PMID: 41992986 [PubMed - indexed for MEDLINE]
	Novel therapeutic strategies for metastatic castrationâ€‘resistant prostate cancer: Beyond androgen receptor pathway inhibition (Review). Int J Oncol Wang Y, Xie Y, Zhao Q. PMID: 41992975 [PubMed - indexed for MEDLINE]
	The role of Bladder EpiCheck(Â®) test in predicting residual tumor after transurethral resection of bladder cancer: Results from a pilot study. Urologia Pacini P, Orecchia L, Asimakopoulos AD, Manfredi M, Lavorgna S, Travaglini S, Pletto S, Abbate N, Feliciangeli V, Finazzi Agrò E, Porpiglia F, Miano R. PMID: 41992667 [PubMed - as supplied by publisher]
	Oncologic Outcomes of Cytoreductive Radical Prostatectomy in Patients With Synchronous Metastatic Castration-Sensitive Prostate Cancer: A Retrospective Analysis. Cancer Med Morozumi K, Numahata K, Oikawa M, Konno M, Kusumoto H, Akito K, Katsumata Y, Sato M, Kaiho Y. PMID: 41992568 [PubMed - indexed for MEDLINE]
	Non-invasive diagnosis strategy integrating PSMA PET/CT and mpMRI for patients with suspected prostate cancer: a multi-center study. BMC Med Wang Y, Tang Y, Chen J, Sha H, Qi L, Hu S, Chen M, Gu D, Chen S, Cai Y. PMID: 41992197 [PubMed - as supplied by publisher]
	Organ-sparing radiotherapy in penile cancer: therapeutic approaches. Int Urol Nephrol Muresan A, Suciu MD, Schitcu VH, Ona V, Varga NI, Muresan CM, Kacso G. PMID: 41991714 [PubMed - as supplied by publisher]
	Ongoing and completed clinical trials on prostate cancer screening using MRI. Eur Radiol Wallström J, Jäderling F, Langkilde F, Arnsrud Godtman R, Bratt O, Thimansson E. PMID: 41989465 [PubMed - as supplied by publisher]
	Acute hemodialysis for cancer-associated acute kidney injury: etiologies, indications, and outcomes from a 25-year single-center experience. Ren Fail Mutis Alan A, Yalin SF, Atas I, Alan O, Altiparmak MR. PMID: 41991909 [PubMed - indexed for MEDLINE]
	Comment on "association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study". J Formos Med Assoc Arya R, Shakya H, Mohapatra AK. PMID: 41991433 [PubMed - as supplied by publisher]
	An integrated restricted mean survival time-based evaluation of efficacy, toxicity, and cost in first-line immunotherapy regimens for metastatic renal cell carcinoma. Urol Oncol Ishiyama Y, Venkatesh A, McGrath J, Rosales RDR, Kanumuambidi JP, Bandyk M, Balaji KC. PMID: 41991383 [PubMed - as supplied by publisher]
	Persistent suicide risk in survivors of testicular cancer: A population-based cohort study. Urol Oncol Cheng KW, Farkouh A, Castillo JK, Jhang D, Song S, Zaki P, Shin J, Hofmann M, Douglawi A, Hu B, Ruckle H, Alsyouf M. PMID: 41991382 [PubMed - as supplied by publisher]
	Novel immunotherapies for prostate cancer. Urol Oncol Mo G, Narayan V. PMID: 41991381 [PubMed - as supplied by publisher]
	Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [(68)Ga]Ga/[(177)Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma. J Nucl Med Wang J, Yan X, Liu M, Yang X, Zheng G, Li X, Cheng Y, Bai C, Zhang Y, Zhu W, Huo L. PMID: 41991341 [PubMed - as supplied by publisher]
	Circulating Tumor DNA Genomic Profiling in (223)Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. J Nucl Med Shiota M, Fujiwara M, Sumiyoshi T, Enokida H, Kamba T, Igawa T, Masumori N, Uemura H, Kamoto T, Higashijima K, Mitsunari K, Uemura H, Kobayashi T, Akamatsu S, Tokunaga S, Isoda T, Ishigami K, Eto M. PMID: 41991340 [PubMed - as supplied by publisher]
	Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study. BMJ Open Re C, Stimpson G, Stewart GD, Bromley J, Archer S, Batley C, Godoy A, Usher-Smith J, Harrison H. PMID: 41991271 [PubMed - indexed for MEDLINE]
	MÃ¼llerian duct cyst and prostate adenocarcinoma in a young adult. BMJ Case Rep Filippidis I, Mantzoukidou N, Evangelou K, Vouros I, Sakalis V. PMID: 41991234 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 177574

Seite 1 von 8879

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung